Dearn S, Rahman M, Lewis A, Ahmed Z, Eggo M C, Ahmed A
Department of Reproductive and Vascular Biology, Birmingham Women's Hospital, University of Birmingham, Edgbaston, UK.
Mol Med. 2000 Jan;6(1):37-49.
Impairment of the fertility in the platelet-activating factor (PAF) receptor transgenic female mice suggests changes in PAF functions can influence uterine receptivity. We hypothesized that vasodilatory actions of PAF in the uterus was exerted by PAF-mediated nitric oxide (NO) release via activation of isoenzyme-specific protein kinase C (PKC).
Inducible and endothelial NOS was shown by Reverse transcription polymerase chain reaction RT-PCR in cDNA synthesized from RNA extract of proliferative and secretory endometrium as well endometrial epithelial cell lines HEC-1B. The effect of WEB2170, N(G)-monomethyl-L-arginine (L-NMMA) and Ro31-8220 on PAF mediated NO release by HEC-1B cell was determined. PAF induced translocation of PKCalpha in HEC-1B cell and its antagonist effect by Ro 31-8220 was studied by Western immunoblot analysis. PKC isoenzyme regulated by PAF was determined in HEC-1B cell lysate by immunoprecipitation.
PAF-evoked a rapid and concentration-dependent biphasic increase in total NO in human HEC-1B endometrial epithelial cell line [as measured by a Sievers NOA 280A NO Chemiluminescent Analyser.] This increase in NO release was attenuated by the PAF receptor antagonist, WEB2170. Inhibition of NO synthesis by N(G)-monomethyl-L-arginine produced marked dose-dependent attenuation of PAF-mediated NO release, indicating nitric oxide synthase (NOS) activation. PAF-mediated NO release was also inhibited by the PKC inhibitor Ro 31-8220 and by the removal of extracellular calcium, suggesting a dependency on PKC and calcium, respectively. RT-PCR analysis showed expression of inducible NOS and endothelial NOS in human endometrium, myometrium and HEC-1B cells. Western immunoblot analysis showed PKCalpha, betaII and iota were the principal isozymes present in the HEC-1B cell line and normal endometrium, suggesting that both HEC-1B cells and normal endometrium have similar PKC isozymes. PAF induced the translocation of both PKCalpha and PKCiota within the time frame of NO release. The translocation of PKCalpha, but not PKCiota, was susceptible to inhibition by Ro 31-8220 that also inhibited PAF-evoked NO release, suggesting that PKCalpha is the principal isozyme involved in this process and that eNOS may be a substrate for PKCalpha. Kinase assays performed using immunoprecipitated PKCalpha showed that PAF (1 nM) activated PKCalpha that was inhibited by co-incubation with Ro31-8220 and Ca(2+)-free medium.
This study demonstrates that PAF-stimulated NO release via PKCalpha in epithelial cells might regulate endometrial functions such as implantation and menstruation.
血小板活化因子(PAF)受体转基因雌性小鼠的生育能力受损,提示PAF功能的改变可能影响子宫容受性。我们推测,PAF在子宫中的血管舒张作用是通过激活同工酶特异性蛋白激酶C(PKC)介导的一氧化氮(NO)释放来实现的。
通过逆转录聚合酶链反应(RT-PCR),在从增殖期和分泌期子宫内膜以及子宫内膜上皮细胞系HEC-1B的RNA提取物合成的cDNA中显示诱导型和内皮型一氧化氮合酶。测定了WEB2170、N(G)-单甲基-L-精氨酸(L-NMMA)和Ro31-8220对HEC-1B细胞PAF介导的NO释放的影响。通过蛋白质免疫印迹分析研究了PAF诱导的PKCα在HEC-1B细胞中的转位及其被Ro 31-8220的拮抗作用。通过免疫沉淀在HEC-1B细胞裂解物中测定受PAF调节的PKC同工酶。
PAF在人HEC-1B子宫内膜上皮细胞系中引起总NO的快速且浓度依赖性双相增加[通过Sievers NOA 280A NO化学发光分析仪测量]。PAF受体拮抗剂WEB2170减弱了这种NO释放的增加。N(G)-单甲基-L-精氨酸对NO合成的抑制产生了PAF介导的NO释放的明显剂量依赖性减弱,表明一氧化氮合酶(NOS)被激活。PAF介导的NO释放也被PKC抑制剂Ro 31-8220和去除细胞外钙所抑制,分别提示对PKC和钙的依赖性。RT-PCR分析显示诱导型NOS和内皮型NOS在人子宫内膜、子宫肌层和HEC-1B细胞中表达。蛋白质免疫印迹分析显示PKCα、βII和ι是HEC-1B细胞系和正常子宫内膜中存在的主要同工酶,提示HEC-1B细胞和正常子宫内膜具有相似的PKC同工酶。PAF在NO释放的时间范围内诱导PKCα和PKCι的转位。PKCα的转位,但不是PKCι的转位,易受Ro 31-8220的抑制,Ro 31-8220也抑制PAF诱导的NO释放,提示PKCα是参与此过程的主要同工酶,且内皮型一氧化氮合酶(eNOS)可能是PKCα的底物。使用免疫沉淀的PKCα进行的激酶测定表明,PAF(1 nM)激活PKCα,与Ro31-8220和无钙培养基共同孵育可抑制该激活。
本研究表明,PAF通过上皮细胞中的PKCα刺激NO释放,可能调节诸如着床和月经等子宫内膜功能。